Cogent Biosciences Inc (NASDAQ:COGT)
| 8.56 Delayed Data As of Jun 22 |  -0.75 / -8.06%Today’s Change | 1.61 Today|||52-Week Range 14.88 | -23.78% Year-to-Date |
Latest COGT News | Press Releases
No recent news for Cogent Biosciences Inc.
Today’s Trading
| Previous close | 9.30 |
| Today’s open | 9.28 |
| Day’s range | 8.41 - 9.34 |
| Volume | 350,325 |
| Average volume (3 months) | 332,324 |
| Market cap | $356.1M |
Data as of 4:00pm ET, 06/22/2021
Growth & Valuation
| Earnings growth (last year) | -287.13% |
| Earnings growth (this year) | +91.06% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -65.02% |
| P/E ratio | NM |
| Price/Sales | 15.81 |
| Price/Book | 2.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WVEWAVE Life Sciences L... | -0.29 | -4.12% |
| CRMDCorMedix Inc | -0.03 | -0.39% |
| ALPNAlpine Immune Scienc... | -0.26 | -2.79% |
| ---- |
Data as of 3:59pm ET, 06/22/2021
Financials
| Next reporting date | August 16, 2021 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$74.8M |
| Net profit margin | -950.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
